✦ LIBER ✦

Poly (ADP ribose) Polymerase-1/2 Inhibition with Veliparib Enhances Radiosensitization of Pancreas Cancer In Vivo

✍ Scribed by R. Tuli; A. Surmak; A. Hacker-Prietz; J.M. Herman

Book ID: 118455913
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 53 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of poly (ADP-ribose) polymera

Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells

✍ J.A. Muñoz-Gámez; R. Quiles-Pérez; A. Ruiz-Extremera; A.B. Martín-Álvarez; Laura 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 921 KB

Enhanced poly(ADP-ribose) polymerase-1 a

Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo

✍ Olaf Crome; Thorsten R. Doeppner; Sönke Schwarting; Barbara Müller; Mathias Bähr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

## Abstract Recombinant tissue plasminogen activator (rt‐PA) treatment improves functional outcome after acute ischemic stroke, inducing reperfusion by its thrombolytic activity. Conversely, there is evidence that rt‐PA can mediate neuronal damage after ischemic brain injury in vivo. In addition to

Inhibition of telomerase activity by red

Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene

✍ Utpal Ghosh; Nilanjana Das; Nitai P. Bhattacharyya 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Oral poly(ADP-ribose) polymerase inhibit

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

✍ Andrew Tutt; Mark Robson; Judy E Garber; Susan M Domchek; M William Audeh; Jeffr 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 594 KB

Oral poly(ADP-ribose) polymerase inhibit

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

✍ M William Audeh; James Carmichael; Richard T Penson; Michael Friedlander; Bethan 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 268 KB

Poly(ADP-ribose) polymerase-1 modulation

Poly(ADP-ribose) polymerase-1 modulation of in vivo response of brain hypoxia-inducible factor-1 to hypoxia/reoxygenation is mediated by nitric oxide and factor inhibiting HIF

✍ Rubén Martínez-Romero; Ana Cañuelo; Esther Martínez-Lara; Francisco Javier Olive 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 690 KB